Table 2.
Routine interferents that can impact biomarker assays*.
| Common endogenous interferents | Interferent concentrations to test | Examples of causes of high interferent concentrations | Examples of assays impacted by interferent |
|---|---|---|---|
| Hemolysate (Hemoglobin) | 0 - 500 mg/dL | hemolysis | Potassium, aspartate transaminase (AST), amylase, calcium, phosphorus, magnesium, total protein, and total and direct bilirubin |
| Triglycerides | 0 - 1000 mg/dL (CLSI recommendation 3000 mg/dL) | hyperlipemia | phosphorus, creatinine, total protein, calcium, hemoglobin |
| Total Protein (from Albumin and gamma-globulins) | 0 - 12 g/dL | dehydration, multiple myeloma | carbon dioxide, apolipoprotein AI, and apolipoprotein B |
| Bilirubin, conjugated | 0 - 20 mg/dL | hemolysis, gall bladder disease | Creatinine, total protein and assays that use a peroxidase as the detection system |
| Bilirubin unconjugated | 0 - 20 mg/dL | liver disease | assays that use a peroxidase as the detection system |
modified from information available online from Sun Diagnostics (https://sundiagnostics.us/assurance/); CLSI, Clinical and Laboratory Standards Institute